The first virtual BioSolveIT DrugSpace Symposium covers the trinity of drug discovery: Targets, compounds, and spaces.
Experts from academia, the pharmaceutical industry, and chemical suppliers disclose current developments and unprecedented innovations to tackle future challenges in drug discovery. The symposium features interdisciplinary cross-talks between computational approaches, medicinal chemistry cases, crystallography, synthesis, small-compound evolution, and the handling of zillions of compounds in reasonable time.
Medicinal chemists, decision makers, representatives of any pharmaceutical- and medicine-related business, undergraduate and Ph.D. students, researchers, and everybody interested in future technologies and state-of-the-art drug development — you are cordially invited to participate. Plenty of leeway for discussion with the audience is provided.
The DrugSpace Symposium takes place at 21-22 April 2021 (4 pm - 8 pm CEST), and the registration is free-of-charge.
Safety Data Scientist/Principal Investigator
EMBL-EBI/University of Vienna
Center for Bioinformatics/University of Hamburg
Global Head Computational Chemistry & Biologics
Johnson & Johnson
Enthusiasts of Chemical Spaces are invited to join the Chemical Space Club on LinkedIn.
Share information, early announcements, publications, success stories, and anything else related to huge chemistry spaces and databases. Become a member, and feel free to contribute.